The relationship between glycated haemoglobin and blood glucose-lowering treatment trajectories in type 2 diabetes: The Fremantle Diabetes Study Phase II.

Published in: Diabetes, obesity & metabolism (2023)

These data demonstrate diabetes duration-dependent heterogeneity in glycaemic and treatment profiles and related clinical and laboratory variables, which have implications for management.

Keyphrases

type diabetes
glycemic control
blood glucose
phase ii
cardiovascular disease
clinical trial
depressive symptoms
open label
insulin resistance
blood pressure
randomized controlled trial
machine learning
adipose tissue
single cell
electronic health record
study protocol